The toxicology is less of a concern because of RC110 had no issues it's much of the same thing so for that the risk of failure is extremely low.
This is why the delivery of RC220 is the real challenge to get it delivered it the timeframe they have set out.
I'm sure a lot of people are waiting on the sidelines waiting to enter and most probably waiting for that announcement to exit also.
The arrival of RC220 is a start of a new exciting chapter for RAC.
The real moves will definitely be results but people will be happy to enter knowing we actually have a drug to be used.
Anyway that's my way of thinking I could be wrong I guess
RAC - Charts & Price Action, page-19417
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |